Regenerative Health and Wellness: The Future of Personalized Medicine
Written by Matt Houston on 4/22/2024
Regulatory Environment and Accelerating Access
The federal regulatory environment, including legislation like the 21st Century Cures Act, aims to create an accelerated path to market for new therapies. Nonetheless, ensuring that new approaches to regenerative medicine, such as customized treatment plans and alternative medicine practices, meet strict safety standards is imperative.
| Key Regulatory Focus Areas | Description |
|---|---|
| Biomanufacturing Standards | Ensure quality control in the production of biological assets. |
| Clinical Practice Standards | Govern the application of regenerative treatments in healthcare. |
| Educational Outreach | Provide patient and practitioner education on new treatments. |
Navigating the tension between rapid access and thorough evaluation is a crucial consideration, demanding a balance between innovative imperatives and the maintenance of rigorous health care standards.
